Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of $0.21, $0.16 better than the analyst estimate of $0.05. Revenue for the quarter came in at $117.77 million versus the consensus estimate of $101.73 million.

GUIDANCE:

Aspen Aerogels sees FY2024 revenue of $390 million, versus the consensus of $387.3 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.